Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1220.0000 12.90 (1.07%)

NSE May 14, 2025 15:31 PM

Volume: 1.2M

Dr. Reddy's Laboratories Ltd.

29 Oct 2022

1220.00

1.07%

Dr Reddy's Labs (HOLD): US launch of gRevlimid buoys quarter

Hold: Dr. Reddy's Laboratories Ltd.

BOB Capital Markets Ltd.

Q2 revenue up 9% YoY on sales of gRevlimid in the US; gross margin expansion aids EBITDA growth of 42% YoY

KRChoksey increased Accumulate price target of Dr. Reddy's Laboratories Ltd. to 1324.0 on 13 May, 2025.